2018 Scientific Committee

 

Dr. Michael Fradley, MD

GCOS 2018 Co-Chair; Assistant Professor of Medicine, University of South Florida; Cardiologist and Co-Director, Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

founder

Dr. Fradley is an Assistant Professor of Medicine at the University of South Florida with a joint appointment as an Assistant Member at the H. Lee Moffitt Cancer Center and Research Institute. He is the director of the combined Moffitt Cancer Center-University of South Florida Cardio-Oncology program. He earned his B.S at Yale University and his MD degree at the Johns Hopkins University School of Medicine. 

Read More...

He remained at Johns Hopkins for internal medicine residency and then went on to complete fellowships in both cardiology and clinical cardiac electrophysiology at Massachusetts General Hospital. His research focuses on all aspects of cardio-oncology, however as a trained electrophysioloigst, Dr. Fradley has particular interest in the diagnosis and management of arrhythmic complications associated with traditional and novel cancer therapies. He has co-authored numerous articles in the field of cardio-oncology. He is also actively involved in undergraduate and graduate medical education mentoring medical students, residents and fellows. He developed and serves as the program director for cardio-oncology fellowship at the University of South Florida and Moffitt Cancer Center. He is the co-director of the biomedical research tract in the Scholarly Concentrations Program at the University of South Florida, Morsani College of Medicine. He is also the medical director for the Harvey Simulation Elective and teaches the cardiovascular pathophysiology course for the second year medical students.  

Dr. Roohi Ismail-Khan, MD, MSc

GCOS 2018 Co-Chair; Medical Oncologist and Co-Director, Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

founder

Dr. Roohi Ismail-Khan is a medical oncologist in the Department of Breast Oncology at Moffitt Cancer Center. Dr. Ismail-Khan’s research interests include reducing or eliminating long-term effects of chemotherapy to improve quality of life. Dr. Ismail-Khan’s research interests include reducing or eliminating long-term effects of chemotherapy to improve quality of life. 

Read More...

She is also focused on triple negative breast cancer; an aggressive disease that may respond well to chemotherapy, but often recurs and spreads. She serves as principal investigator on multiple investigator and pharmaceutical sponsored clinical trials. She is the co-director of the new Cardio-Oncology program working closely with Dr. Fradley, director of the program. Dr. Ismail-Kahn is also an active teacher/mentor for USF medical students, internal medicine USF residents, and medical oncology fellows.